Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Nephron Blockade in Acute Heart Failure (NEB-HF)
NCT04465123Phase 3Unknown
- Sponsor
- Chiang Mai University
- Start
- Aug 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone, hydrochlorothiazide in Acute Heart Failure (AHF), sponsored by Chiang Mai University. Status: unknown.
02
Drugs
spironolactonehydrochlorothiazide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT04465123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465123.